| Product Code: ETC13276292 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Gastritis Market was valued at USD 1.5 Billion in 2024 and is expected to reach USD 2.2 Billion by 2031, growing at a compound annual growth rate of 2.60% during the forecast period (2025-2031).
The global gastritis market is expected to witness steady growth due to the increasing prevalence of gastritis worldwide. Factors such as the rising geriatric population, unhealthy dietary habits, and the high prevalence of Helicobacter pylori infection are contributing to the market growth. The market is driven by the availability of various treatment options, including proton pump inhibitors, antibiotics, and antacids. Additionally, the increasing awareness about gastrointestinal disorders and the rising healthcare expenditure in developing countries are further fueling market expansion. However, challenges such as side effects associated with medications and the lack of early diagnosis in some regions may hinder market growth. Overall, technological advancements in diagnostic tools and treatment options are expected to drive the global gastritis market in the coming years.
The Global Gastritis Market is witnessing a surge in demand for proton pump inhibitors (PPIs) and H2 receptor antagonists due to the increasing prevalence of gastritis worldwide. The market is also experiencing a growing focus on developing novel treatment options such as mucosal protective agents and antibiotics to address the rising cases of Helicobacter pylori infection-induced gastritis. Additionally, the adoption of advanced diagnostic techniques like endoscopy and biopsy for accurate diagnosis of gastritis is driving market growth. The rising awareness about the importance of early diagnosis and treatment of gastritis, coupled with increasing healthcare expenditure in emerging economies, presents lucrative opportunities for market players to expand their presence in the Global Gastritis Market. Collaboration with healthcare providers and research institutions to develop innovative therapies and personalized treatment approaches could further enhance market growth.
The Global Gastritis Market faces several challenges, including the rising prevalence of gastritis due to factors such as unhealthy dietary habits, stress, and bacterial infections. Additionally, the lack of specific diagnostic tools for differentiating between gastritis subtypes can lead to misdiagnosis and inappropriate treatment. Limited awareness about gastritis among the general population also poses a challenge in early detection and management. Furthermore, the presence of alternative treatment options, such as over-the-counter medications and home remedies, can hinder the market growth of prescription drugs and other medical interventions. Overall, addressing these challenges requires increased education and awareness efforts, advancements in diagnostic technologies, and the development of more effective and targeted treatment options for gastritis patients.
The global gastritis market is primarily driven by factors such as the increasing prevalence of gastric disorders, changing dietary habits leading to higher incidence of gastritis, rising geriatric population susceptible to gastrointestinal issues, and the growing awareness about early diagnosis and treatment options. Additionally, the availability of advanced diagnostic technologies and treatment modalities, along with the continuous research and development activities in the field of gastroenterology, are contributing to the growth of the gastritis market globally. The rising healthcare expenditure and improving healthcare infrastructure in emerging economies are also expected to fuel market growth. Overall, the increasing burden of gastritis and related complications, coupled with the focus on preventive healthcare measures, are key drivers shaping the global gastritis market.
Government policies related to the Global Gastritis Market focus on regulating the manufacturing, distribution, and marketing of gastritis medications to ensure safety, efficacy, and quality standards. Regulatory agencies such as the FDA in the US and the EMA in Europe play a crucial role in approving and monitoring gastritis treatments to protect public health. These policies also aim to promote research and development in the field of gastritis by providing incentives for companies to invest in innovative therapies. Additionally, governments may implement pricing and reimbursement policies to make gastritis treatments more accessible to patients, especially in low-income populations. Overall, government policies in the Global Gastritis Market are designed to balance the interests of pharmaceutical companies, healthcare providers, and patients while ensuring the effectiveness and affordability of gastritis treatments.
The Global Gastritis Market is expected to witness steady growth in the coming years due to factors such as the increasing prevalence of gastritis worldwide, rising adoption of unhealthy dietary habits, and the growing geriatric population. Technological advancements in diagnostic procedures and treatment options are also likely to drive market growth. Additionally, the rising awareness about gastrointestinal disorders and the availability of innovative therapies are anticipated to contribute to market expansion. However, factors such as the high cost of treatment and the potential side effects associated with certain medications may pose challenges to market growth. Overall, the Global Gastritis Market is projected to experience moderate growth in the foreseeable future, with opportunities for market players to introduce novel therapeutic solutions and expand their market presence.
In the Global Gastritis Market, different regions exhibit varying trends and dynamics. Asia is expected to dominate the market growth due to the high prevalence of gastritis in countries like India and China. North America and Europe are also significant markets with advanced healthcare infrastructure and a growing geriatric population. In the Middle East and Africa, the market is driven by increasing healthcare expenditure and rising awareness about gastrointestinal diseases. Latin America is witnessing steady growth in the gastritis market due to improving healthcare facilities and rising healthcare investments. Overall, the global gastritis market shows promising growth opportunities across regions, driven by factors such as increasing prevalence of gastritis, growing healthcare awareness, and advancements in treatment options.
Global Gastritis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Gastritis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Gastritis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Gastritis Market - Industry Life Cycle |
3.4 Global Gastritis Market - Porter's Five Forces |
3.5 Global Gastritis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Gastritis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Gastritis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Global Gastritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Gastritis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Global Gastritis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Gastritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Gastritis Market Trends |
6 Global Gastritis Market, 2021 - 2031 |
6.1 Global Gastritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Gastritis Market, Revenues & Volume, By Acid Blocking Medications, 2021 - 2031 |
6.1.3 Global Gastritis Market, Revenues & Volume, By Prevacid 24HR (lansoprazole), 2021 - 2031 |
6.1.4 Global Gastritis Market, Revenues & Volume, By Nexium 24HR, 2021 - 2031 |
6.1.5 Global Gastritis Market, Revenues & Volume, By Acid Reducing Medications, 2021 - 2031 |
6.1.6 Global Gastritis Market, Revenues & Volume, By Nexium, 2021 - 2031 |
6.1.7 Global Gastritis Market, Revenues & Volume, By Prevacid, 2021 - 2031 |
6.1.8 Global Gastritis Market, Revenues & Volume, By Antacids, 2021 - 2031 |
6.1.9 Global Gastritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Gastritis Market, Revenues & Volume, By Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Gastritis Market, Revenues & Volume, By Acute Gastritis, 2021 - 2031 |
6.2.3 Global Gastritis Market, Revenues & Volume, By Chronic Gastritis, 2021 - 2031 |
6.2.4 Global Gastritis Market, Revenues & Volume, By Erosive Gastritis, 2021 - 2031 |
6.2.5 Global Gastritis Market, Revenues & Volume, By Non-Erosive Gastritis, 2021 - 2031 |
6.3 Global Gastritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Gastritis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Gastritis Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.4 Global Gastritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Gastritis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Gastritis Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 Global Gastritis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.5 Global Gastritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Gastritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Gastritis Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Gastritis Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.5.4 Global Gastritis Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.5.5 Global Gastritis Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Gastritis Market, Overview & Analysis |
7.1 North America Gastritis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Gastritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Gastritis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Gastritis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Gastritis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Gastritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Gastritis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.5 North America Gastritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Gastritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7 North America Gastritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Gastritis Market, Overview & Analysis |
8.1 Latin America (LATAM) Gastritis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Gastritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Gastritis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Gastritis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Gastritis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Gastritis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Gastritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Gastritis Market, Revenues & Volume, By Type, 2021 - 2031 |
8.5 Latin America (LATAM) Gastritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Gastritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.7 Latin America (LATAM) Gastritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Gastritis Market, Overview & Analysis |
9.1 Asia Gastritis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Gastritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Gastritis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Gastritis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Gastritis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Gastritis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Gastritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Gastritis Market, Revenues & Volume, By Type, 2021 - 2031 |
9.5 Asia Gastritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Gastritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.7 Asia Gastritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Gastritis Market, Overview & Analysis |
10.1 Africa Gastritis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Gastritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Gastritis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Gastritis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Gastritis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Gastritis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Gastritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Gastritis Market, Revenues & Volume, By Type, 2021 - 2031 |
10.5 Africa Gastritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Gastritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.7 Africa Gastritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Gastritis Market, Overview & Analysis |
11.1 Europe Gastritis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Gastritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Gastritis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Gastritis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Gastritis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Gastritis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Gastritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Gastritis Market, Revenues & Volume, By Type, 2021 - 2031 |
11.5 Europe Gastritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Gastritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.7 Europe Gastritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Gastritis Market, Overview & Analysis |
12.1 Middle East Gastritis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Gastritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Gastritis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Gastritis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Gastritis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Gastritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Gastritis Market, Revenues & Volume, By Type, 2021 - 2031 |
12.5 Middle East Gastritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Gastritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.7 Middle East Gastritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Gastritis Market Key Performance Indicators |
14 Global Gastritis Market - Export/Import By Countries Assessment |
15 Global Gastritis Market - Opportunity Assessment |
15.1 Global Gastritis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Gastritis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Gastritis Market Opportunity Assessment, By Type, 2021 & 2031F |
15.4 Global Gastritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Gastritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.6 Global Gastritis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Gastritis Market - Competitive Landscape |
16.1 Global Gastritis Market Revenue Share, By Companies, 2024 |
16.2 Global Gastritis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |